{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:33:09Z","timestamp":1773387189587,"version":"3.50.1"},"reference-count":75,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Immunomodulatory drugs, such as thalidomide and related compounds, potentiate T-cell effector functions. Cereblon (CRBN), a substrate receptor of the DDB1-cullin-RING E3 ubiquitin ligase complex, is the only molecular target for this drug class, where drug-induced, ubiquitin-dependent degradation of known \u201cneosubstrates,\u201d such as IKAROS, AIOLOS, and CK1\u03b1, accounts for their biological activity. Far less clear is whether these CRBN E3 ligase-modulating compounds disrupt the endogenous functions of CRBN. We report that CRBN functions in a feedback loop that harnesses antigen-specific CD8+ T-cell effector responses. Specifically, Crbn deficiency in murine CD8+ T cells augments their central metabolism manifested as elevated bioenergetics, with supraphysiological levels of polyamines, secondary to enhanced glucose and amino acid transport, and with increased expression of metabolic enzymes, including the polyamine biosynthetic enzyme ornithine decarboxylase. Treatment with CRBN-modulating compounds similarly augments central metabolism of human CD8+ T cells. Notably, the metabolic control of CD8+ T cells by modulating compounds or Crbn deficiency is linked to increased and sustained expression of the master metabolic regulator MYC. Finally, Crbn-deficient T cells have augmented antigen-specific cytolytic activity vs melanoma tumor cells, ex vivo and in vivo, and drive accelerated and highly aggressive graft-versus-host disease. Therefore, CRBN functions to harness the activation of CD8+ T cells, and this phenotype can be exploited by treatment with drugs.<\/jats:p>","DOI":"10.1182\/blood.2019003257","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T17:39:16Z","timestamp":1594921156000},"page":"857-870","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes"],"prefix":"10.1182","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0472-7517","authenticated-orcid":false,"given":"Rebecca S.","family":"Hesterberg","sequence":"first","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"},{"name":"Cancer Biology PhD Program, University of South Florida, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Beatty","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"},{"name":"Department of Immunology, Tianjin Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2017-9576","authenticated-orcid":false,"given":"Mario R.","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Tumor Biology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afua A.","family":"Akuffo","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"},{"name":"Cancer Biology PhD Program, University of South Florida, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Goodheart","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunying","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Tumor Biology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiun","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"},{"name":"Cancer Biology PhD Program, University of South Florida, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle M.","family":"Colin","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen Y.","family":"Alontaga","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"McDaniel","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam W.","family":"Mailloux","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2831-1428","authenticated-orcid":false,"given":"Julia M. R.","family":"Billington","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"},{"name":"Cancer Biology PhD Program, University of South Florida, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8578-7564","authenticated-orcid":false,"given":"Lanzhu","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"},{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-6132","authenticated-orcid":false,"given":"Shonagh","family":"Russell","sequence":"additional","affiliation":[{"name":"Cancer Biology PhD Program, University of South Florida, Tampa, FL;"},{"name":"Department of Cancer Physiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8888-7747","authenticated-orcid":false,"given":"Robert J.","family":"Gillies","sequence":"additional","affiliation":[{"name":"Department of Cancer Physiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Y.","family":"Yun","sequence":"additional","affiliation":[{"name":"Chemical Biology Core, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ayaz","sequence":"additional","affiliation":[{"name":"Chemical Biology Core, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1129-2558","authenticated-orcid":false,"given":"Nicholas J.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9263-7775","authenticated-orcid":false,"given":"Harshani R.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Chemical Biology Core, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Zhong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-5405","authenticated-orcid":false,"given":"Jianing","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lancia N.","family":"Darville","sequence":"additional","affiliation":[{"name":"Proteomics and Metabolomics Core,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-1762","authenticated-orcid":false,"given":"John M.","family":"Koomen","sequence":"additional","affiliation":[{"name":"Proteomics and Metabolomics Core,"},{"name":"Department of Molecular Oncology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiubao","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Immunology, Tianjin Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0332-0224","authenticated-orcid":false,"given":"Jane","family":"Messina","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology and Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8531-7813","authenticated-orcid":false,"given":"Kun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology and Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-009X","authenticated-orcid":false,"given":"Timothy J.","family":"Garrett","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali M.","family":"Rajadhyaksha","sequence":"additional","affiliation":[{"name":"Pediatric Neurology, Pediatrics, Weill Family Brain and Mind Research Institute, and"},{"name":"Graduate Program in Neuroscience, Weill Cornell Medical College, Cornell University, Cornell, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Cleveland","sequence":"additional","affiliation":[{"name":"Department of Tumor Biology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearlie K.","family":"Epling-Burnette","sequence":"additional","affiliation":[{"name":"Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"10","key":"2020081311245145500_B1","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1212\/01.WNL.0000146196.01316.A2","article-title":"A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation","volume":"63","author":"Higgins","year":"2004","journal-title":"Neurology"},{"issue":"5971","key":"2020081311245145500_B2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"issue":"21","key":"2020081311245145500_B3","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa070594","article-title":"Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma","volume":"357","author":"Dimopoulos","year":"2007","journal-title":"N Engl J Med"},{"issue":"21","key":"2020081311245145500_B4","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa070596","article-title":"Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America","volume":"357","author":"Weber","year":"2007","journal-title":"N Engl J Med"},{"issue":"34","key":"2020081311245145500_B5","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1200\/JCO.2005.05.0401","article-title":"Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study","volume":"24","author":"Chanan-Khan","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"2020081311245145500_B6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","article-title":"Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma","volume":"21","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"issue":"6","key":"2020081311245145500_B7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/blood-2015-02-628669","article-title":"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL","volume":"126","author":"Hagner","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2020081311245145500_B8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa041668","article-title":"Efficacy of lenalidomide in myelodysplastic syndromes","volume":"352","author":"List","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"2020081311245145500_B9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.seminhematol.2017.06.003","article-title":"Lenalidomide: myelodysplastic syndromes with del(5q) and beyond","volume":"54","author":"Talati","year":"2017","journal-title":"Semin Hematol"},{"issue":"7512","key":"2020081311245145500_B10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"issue":"7597","key":"2020081311245145500_B11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4(CRBN) ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"issue":"9","key":"2020081311245145500_B12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsmb.2874","article-title":"Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs","volume":"21","author":"Chamberlain","year":"2014","journal-title":"Nat Struct Mol Biol"},{"issue":"14","key":"2020081311245145500_B13","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/onc.2015.245","article-title":"Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors","volume":"35","author":"Gopalakrishnan","year":"2016","journal-title":"Oncogene"},{"issue":"6168","key":"2020081311245145500_B14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"issue":"6241","key":"2020081311245145500_B15","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"issue":"11","key":"2020081311245145500_B16","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.4049\/jimmunol.1301992","article-title":"Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production","volume":"192","author":"O\u2019Brien","year":"2014","journal-title":"J Immunol"},{"issue":"6","key":"2020081311245145500_B17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S1097-2765(02)00711-6","article-title":"The CD8alpha gene locus is regulated by the Ikaros family of proteins","volume":"10","author":"Harker","year":"2002","journal-title":"Mol Cell"},{"issue":"6168","key":"2020081311245145500_B18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science"},{"issue":"7","key":"2020081311245145500_B19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nm.4128","article-title":"Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity","volume":"22","author":"Eichner","year":"2016","journal-title":"Nat Med"},{"issue":"31","key":"2020081311245145500_B20","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1073\/pnas.1502166113","article-title":"Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation","volume":"113","author":"Kang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020081311245145500_B21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"issue":"1","key":"2020081311245145500_B22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-065X.2010.00911.x","article-title":"The metabolic life and times of a T-cell","volume":"236","author":"Michalek","year":"2010","journal-title":"Immunol Rev"},{"issue":"6","key":"2020081311245145500_B23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"issue":"6","key":"2020081311245145500_B24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/08830185.2015.1082178","article-title":"Regulators of Glucose Metabolism in CD4+ and CD8+ T Cells","volume":"35","author":"Palmer","year":"2016","journal-title":"Int Rev Immunol"},{"issue":"4","key":"2020081311245145500_B25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ni.3415","article-title":"Emerging concepts of T cell metabolism as a target of immunotherapy","volume":"17","author":"Chang","year":"2016","journal-title":"Nat Immunol"},{"issue":"6","key":"2020081311245145500_B26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"issue":"2","key":"2020081311245145500_B27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bbr.2011.09.039","article-title":"Behavioral characterization of cereblon forebrain-specific conditional null mice: a model for human non-syndromic intellectual disability","volume":"226","author":"Rajadhyaksha","year":"2012","journal-title":"Behav Brain Res"},{"issue":"5","key":"2020081311245145500_B28","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.0900641","article-title":"Memory-like CD8+ T cells generated during homeostatic proliferation defer to antigen-experienced memory cells","volume":"183","author":"Cheung","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"2020081311245145500_B29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4049\/jimmunol.176.1.301","article-title":"Molecular, cellular, and antigen requirements for development of age-associated T cell clonal expansions in vivo","volume":"176","author":"Messaoudi","year":"2006","journal-title":"J Immunol"},{"issue":"26","key":"2020081311245145500_B30","doi-asserted-by":"crossref","first-page":"15818","DOI":"10.1073\/pnas.2636938100","article-title":"Antigen-driven effector CD8 T cell function regulated by T-bet","volume":"100","author":"Sullivan","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2020081311245145500_B31","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ni1268","article-title":"Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin [Nat Immunol. 2006 Jan;7(1):113]","volume":"6","author":"Intlekofer","year":"2005","journal-title":"Nat Immunol"},{"issue":"10","key":"2020081311245145500_B32","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.4049\/jimmunol.0803510","article-title":"Anergic T cells are metabolically anergic","volume":"183","author":"Zheng","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"2020081311245145500_B33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tem.2012.06.005","article-title":"The dynamic regulation of NAD metabolism in mitochondria","volume":"23","author":"Stein","year":"2012","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"2020081311245145500_B34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"issue":"43","key":"2020081311245145500_B43","doi-asserted-by":"crossref","first-page":"44243","DOI":"10.1074\/jbc.M407021200","article-title":"Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like?","volume":"279","author":"Mareeva","year":"2004","journal-title":"J Biol Chem"},{"issue":"10","key":"2020081311245145500_B35","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1172\/JCI69589","article-title":"Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function","volume":"123","author":"Sukumar","year":"2013","journal-title":"J Clin Invest"},{"issue":"6","key":"2020081311245145500_B36","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"issue":"10","key":"2020081311245145500_B37","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00726-016-2275-3","article-title":"Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer","volume":"48","author":"Nakanishi","year":"2016","journal-title":"Amino Acids"},{"issue":"3","key":"2020081311245145500_B38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygeno.2004.11.006","article-title":"Molecular cloning, characterization, and chromosomal assignment of porcine cationic amino acid transporter-1","volume":"85","author":"Cui","year":"2005","journal-title":"Genomics"},{"issue":"25","key":"2020081311245145500_B39","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1074\/jbc.M115.700534","article-title":"Deletion of amino acid transporter ASCT2 (SLC1A5) reveals an essential role for transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to sustain glutaminolysis in cancer cells","volume":"291","author":"Br\u00f6er","year":"2016","journal-title":"J Biol Chem"},{"issue":"2","key":"2020081311245145500_B40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.1100002","article-title":"Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity","volume":"187","author":"Cantor","year":"2011","journal-title":"J Immunol"},{"issue":"2","key":"2020081311245145500_B41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1248\/bpb.29.234","article-title":"Role of polyamines derived from arginine in differentiation and proliferation of human blood cells","volume":"29","author":"Maeda","year":"2006","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"2020081311245145500_B42","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20171068","article-title":"4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses","volume":"215","author":"Menk","year":"2018","journal-title":"J Exp Med"},{"issue":"10","key":"2020081311245145500_B44","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, Metabolism, and Cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov"},{"issue":"5","key":"2020081311245145500_B45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ccr.2005.03.036","article-title":"Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation","volume":"7","author":"Nilsson","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"2020081311245145500_B46","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1038\/s41598-018-28107-4","article-title":"A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation","volume":"8","author":"Castell","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"2020081311245145500_B47","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.bbmt.2014.04.014","article-title":"Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation","volume":"20","author":"Alsina","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020081311245145500_B48","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1172\/JCI82587","article-title":"Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation","volume":"126","author":"Nguyen","year":"2016","journal-title":"J Clin Invest"},{"issue":"12","key":"2020081311245145500_B49","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1172\/JCI39692","article-title":"PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice","volume":"119","author":"Valenzuela","year":"2009","journal-title":"J Clin Invest"},{"issue":"1","key":"2020081311245145500_B50","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4049\/jimmunol.1401618","article-title":"T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function","volume":"194","author":"Fu","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"2020081311245145500_B51","first-page":"92","article-title":"Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease","volume":"72","author":"Imoto","year":"2000","journal-title":"Int J Hematol"},{"issue":"2","key":"2020081311245145500_B52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10238-014-0285-6","article-title":"Myc and AP-1 expression in T cells and T-cell activation in patients after hematopoietic stem cell transplantation","volume":"15","author":"Trop-Steinberg","year":"2015","journal-title":"Clin Exp Med"},{"issue":"21","key":"2020081311245145500_B53","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1128\/MCB.21.21.7137-7149.2001","article-title":"Zap-70-independent Ca(2+) mobilization and Erk activation in Jurkat T cells in response to T-cell antigen receptor ligation","volume":"21","author":"Shan","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"23","key":"2020081311245145500_B54","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1182\/blood-2012-12-476218","article-title":"MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner","volume":"121","author":"Shindo","year":"2013","journal-title":"Blood"},{"issue":"13","key":"2020081311245145500_B55","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1182\/blood-2008-03-147322","article-title":"STAT-3 and ERK 1\/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease","volume":"112","author":"Lu","year":"2008","journal-title":"Blood"},{"key":"2020081311245145500_B56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trim.2016.01.005","article-title":"Impaired CD98 signaling protects against graft-versus-host disease by increasing regulatory T cells","volume":"35","author":"Nishio","year":"2016","journal-title":"Transpl Immunol"},{"issue":"2","key":"2020081311245145500_B57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/jpet.114.218099","article-title":"Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease","volume":"351","author":"Glick","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2020081311245145500_B58","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1471-4159.2005.03344.x","article-title":"Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain","volume":"94","author":"Jo","year":"2005","journal-title":"J Neurochem"},{"issue":"3","key":"2020081311245145500_B59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10048-008-0128-2","article-title":"Dysregulation of large-conductance Ca2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p.R419X mutation","volume":"9","author":"Higgins","year":"2008","journal-title":"Neurogenetics"},{"issue":"6","key":"2020081311245145500_B61","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.molcel.2016.02.032","article-title":"Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon","volume":"61","author":"Nguyen","year":"2016","journal-title":"Mol Cell"},{"issue":"3","key":"2020081311245145500_B62","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbamcr.2011.01.005","article-title":"Functional modulation of AMP-activated protein kinase by cereblon","volume":"1813","author":"Lee","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"7599","key":"2020081311245145500_B63","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature17442","article-title":"Metabolic maintenance of cell asymmetry following division in activated T lymphocytes","volume":"532","author":"Verbist","year":"2016","journal-title":"Nature"},{"issue":"6","key":"2020081311245145500_B64","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/ni.3438","article-title":"Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation","volume":"17","author":"Pollizzi","year":"2016","journal-title":"Nat Immunol"},{"issue":"3","key":"2020081311245145500_B65","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/jpet.110.170555","article-title":"In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc\/Max dimerization","volume":"335","author":"Clausen","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2020081311245145500_B66","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1101\/gad.6.4.642","article-title":"Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant","volume":"6","author":"Bernstein","year":"1992","journal-title":"Genes Dev"},{"issue":"12","key":"2020081311245145500_B67","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1101\/gad.1920310","article-title":"Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells","volume":"24","author":"Choi","year":"2010","journal-title":"Genes Dev"},{"issue":"4","key":"2020081311245145500_B68","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/path.5273","article-title":"Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer","volume":"248","author":"Liu","year":"2019","journal-title":"J Pathol"},{"issue":"23","key":"2020081311245145500_B69","first-page":"6310","article-title":"Regulation of N-myc transcript stability in human neuroblastoma and retinoblastoma cells","volume":"47","author":"Amy","year":"1987","journal-title":"Cancer Res"},{"issue":"5","key":"2020081311245145500_B70","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1006\/jmbi.2000.3745","article-title":"Rapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB","volume":"299","author":"Clement","year":"2000","journal-title":"J Mol Biol"},{"issue":"5","key":"2020081311245145500_B71","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.immuni.2008.04.002","article-title":"MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation","volume":"28","author":"Dorsett","year":"2008","journal-title":"Immunity"},{"key":"2020081311245145500_B72","first-page":"1","article-title":"Making myc","volume":"302","author":"Liu","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"16","key":"2020081311245145500_B73","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1158\/0008-5472.CAN-12-0026","article-title":"Translation regulation as a therapeutic target in cancer","volume":"72","author":"Grzmil","year":"2012","journal-title":"Cancer Res"},{"issue":"9","key":"2020081311245145500_B74","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/j.1460-2075.1988.tb03133.x","article-title":"Multiple mechanisms regulate c-myc gene expression during normal T cell activation","volume":"7","author":"Lindsten","year":"1988","journal-title":"EMBO J"},{"issue":"23","key":"2020081311245145500_B75","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1091\/mbc.e09-07-0550","article-title":"Polyamines regulate c-Myc translation through Chk2-dependent HuR phosphorylation","volume":"20","author":"Liu","year":"2009","journal-title":"Mol Biol Cell"},{"issue":"12","key":"2020081311245145500_B76","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood-2012-06-438911","article-title":"B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways","volume":"120","author":"Allen","year":"2012","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/7\/857\/1752648\/bloodbld2019003257.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/7\/857\/1752648\/bloodbld2019003257.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T04:37:48Z","timestamp":1597379868000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/136\/7\/857\/455314\/Cereblon-harnesses-Mycdependent-bioenergetics-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,8,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019003257","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]}}}